๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials in this register

19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Intrathecal Morphine for Postoperative Analgesia in Major Laparoscopic Abdominal Surgery, a IMPACT-Scope Trial
NCT06666985Patients Undergoing Major Laparoscopic Abdominal Surgery
First Affiliated Hospital, Sun Yat-Sen University
Phase 4
700
Guangzhou
2024-12-16
Recruiting
A Study of Maribavir in Chinese Adults With Cytomegalovirus (CMV) Infections
NCT06439342Cytomegalovirus (CMV)
Takeda
Phase 3
20
Hefei, Chongqing, Guangzhou, Zhengzhou, Wuhan, Suzhou, Beijing, Tianjin
2024-12-16
Recruiting
An Intervention Study on Transcranial Photobiomodulation in Children With Attention Deficit Hyperactivity Disorder
NCT06685601ADHD - Attention Deficit Disorder With Hyperactivity
Qilu Hospital of Shandong University
Not applicable
60
Jinan
2024-12-16
Recruiting
Study of BM230 in Patients With Advanced Solid Tumors
NCT06644300Solid Tumor
Suzhou Biomissile Pharmaceuticals Co., Ltd.
Phase 1
123
Bengbu, Shanghai, Hangzhou
2024-12-16
Recruiting
Autologous BCMA-targeted CAR-T Cell Injection for Relapsed/Refractory Light Chain Amyloidosis
NCT07626476Relapsed/Refractory Light Chain Amyloidosis, AL Amyloidosis, Systemic Light Chain Amyloidosis
Beijing Boren Hospital
Phase EARLY_PHASE1
30
Beijing
2024-12-16
Not yet open
Efficacy and Safety of Intravenous + Oral Vs. Oral Amiodarone in Preventing Recurrence After Catheter Ablation in Patients with Persistent Atrial Fibrillation
NCT06742866Atrial Fibrillation (AF)
Shanghai Chest Hospital
Not applicable
418
Shanghai
2024-12-16
Active, closed
A Phase III Study of KN026 in Combination With HB1801 ยฑ Carboplatin as Neoadjuvant Treatment for Early or Locally Advanced HER2-Positive Breast Cancer
NCT06747338Early or Locally Advanced HER2-positive Breast Cancer
Shanghai JMT-Bio Inc.
Phase 3
520
Shanghai
2024-12-16
Not yet open
Atrial Fibrillation with Heart Failure with Preserved Ejection Fraction: Treatment Strategies-Catheter Ablation Vs. Anti-Atrial Arrhythmia Drugs
NCT06740539HFpEF - Heart Failure with Preserved Ejection Fraction, Atrial Fibrillation (AF)
Shanghai Chest Hospital
Not applicable
304
Shanghai
2024-12-16
Recruiting
Efficacy of Extended Letermovir Prophylaxis to Prevent CMV Reactivation in High-Risk Chinese Adults Undergoing Allogeneic HSCT
NCT06812598Cytomegalovirus Infections, CMV
The First Affiliated Hospital of Soochow University
Not applicable
330
Suzhou
2024-12-16
Recruiting
Clinical Study on the Treatment of Herpes Zoster Pain With Dexmedetomidine Combined With Long-term High Voltage
NCT06978192Herpes Zoster (HZ)
Fenghui Deng
Phase 2
92
Zunyi
2024-12-16
By invitation
Non-invasive Methods for Predicting Decompensation of Chronic Liver Disease
NCT06741904Chronic Liver Disease and Cirrhosis
Nanfang Hospital, Southern Medical University
Observational
2,334
Guangzhou
2024-12-16
Recruiting
Study on the Mechanism of Cognitive Impairment in Patients with Moyamoya Disease
NCT06832839Moyamoya Disease
Beijing Tiantan Hospital
Observational
360
Beijing
2024-12-16
Recruiting
Using Mukbang to Improve Appetite, Nutritional Status and Quality of Life in Children With Cancer
NCT05922553Children With Cancer
Wei XIA, PhD
Not applicable
124
Guangzhou
2024-12-16
Recruiting
Multicenter Real-World Cohort Study Evaluating the Impact of Early Intensive Lipid-Lowering Therapy on the Prognosis of Acute Coronary Syndrome Patients(ELITE-ACS)
NCT06738758Acute Coronary Syndromes
Yun Dai Chen
Observational
6,000
Beijing
2024-12-16
Recruiting
Long-term Follow-up Registry Study of Equecabtagene Autoleucel Injection
NCT07028970Multiple Myeloma
Nanjing IASO Biotechnology Co., Ltd.
Observational
1,500
Beijing, Tianjin, Wuhan, Zhengzhou
2024-12-15
Recruiting
A Randomized Trial Comparing the Efficacy and Safety of Secukinumab with Tofacitinib in the Treatment of Moderate to Severe Hidradenitis Suppurativa in Chinese Patients
NCT06707246Hidradenitis Suppurativa
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
60
Hangzhou
2024-12-15
Recruiting
Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Colorectal Cancer
NCT06718738Colorectal Cancer (CRC)
Beijing Immunochina Medical Science & Technology Co., Ltd.
Phase 1
9
Beijing
2024-12-15
Recruiting
Effects of Transcranial Electrical Stimulation on Cognitive Impairment in CNS Inflammatory Demyelinating Diseases
NCT07029386Idiopathic Inflammatory Demyelinating Disorders of the Central Nervous System
Xuanwu Hospital, Beijing
Not applicable
40
Beijing
2024-12-15
Recruiting
Double Pig Tail Stent-assisted Fixation of Fully Covered Metal Stents for the Treatment of Benign Duodenal Strictures
NCT06736301Benign Duodenal Stricture
Shupei Li
Not applicable
5
Nanjing
2024-12-15
Recruiting
Study on Evaluating the Effectiveness of Statins in the Treatment of Moyamoya Disease
NCT06817434Moyamoya Disease
Beijing Tiantan Hospital
Observational
330
Beijing
2024-12-15
Recruiting
fNIRS-Driven Visual Feedback Training to Restore Walking After Stroke
NCT07014891Stroke
Shengjing Hospital
Not applicable
44
Shenyang
2024-12-15
Recruiting
A Clinical Study on Neoadjuvant Treatment of Resectable Head and Neck Squamous Carcinoma With Immune-targeted Therapy and Lysogenic HSV Virus
NCT06741982HNSCC, Lysogenic HSV Virus, Neoadjuvant Therapy, Immunotherapy
West China Hospital
Phase 1
21
Chengdu
2024-12-15
Not yet open
A Single-Arm, Phase โ… b Study of Golidocitinib Combined With Anti-PD-1 for the Treatment of Previously Treated NSCLC
NCT06690671Lung Cancer, Non-Small Cell
Shanghai Chest Hospital
Phase 1/2
30
Shanghai
2024-12-15
Not yet open
Construction of a Risk Screening Tool for New Psychoactive Substance Misuse Among Adolescents and Young Adults
NCT06714578Drug Misuse, Addiction
Wei XIA, PhD
Observational
1,035
Guangzhou
2024-12-15
Recruiting
Clinical Evaluation of Extended Depth-of-focus Intraocular Lens in Refractive Cataract Surgery: a Randomized Controlled Trial
NCT06658119Cataract
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
90
Hangzhou
2024-12-15
Recruiting
Evaluation of a CAM System for Colorectal Polyp Size Measurement
NCT06715384Colorectal Polyp, Colorectal Adenoma
Changhai Hospital
Not applicable
168
Shanghai
2024-12-15
Active, closed
Tirellizumab Combined With TP Neoadjuvant Therapy in the Treatment of Early Oral Squamous Cell Carcinoma ๏ผˆHNC-SYSU-005๏ผ‰
NCT07267286HNSCC, PD-1
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
60
Guangzhou
2024-12-15
By invitation
INK Cells As Maintenance Therapy After Chemoradiotherapy for Small Cell Lung Cancer
NCT06747832Small Cell Lung Cancer
Guangzhou Ruixin Biotechnological Co., LTD
Phase EARLY_PHASE1
10
Weifang
2024-12-15
Recruiting
Universal CNK-UT Therapy for Refractory aGVHD
NCT06750133Acute Graft-versus-Host Disease
First Affiliated Hospital of Zhejiang University
Phase 1
23
Fuzhou, Hangzhou
2024-12-14
Recruiting
Efficacy and Influencing Factors of ALIC-NAc Deep Brain Stimulation in Treatment-Refractory Obsessive-Compulsive Disorder
NCT07031544Obsessive - Compulsive Disorder
Shanghai Mental Health Center
Not applicable
60
Guangzhou, Shijiazhuang, Xinxiang, Nanchang, Taiyuan, Mianyang, Shanghai, Tianjin
2024-12-14
Recruiting
Phase Ib Trial of HS-20117 in Combination With Other Drugs in Advanced Solid Tumors
NCT06621563Solid Tumors, Non-Small Cell Lung Cancer, Colorectal Cancer
Hansoh BioMedical R&D Company
Phase 1
780
Tianjin
2024-12-14
Active, closed
Study to Evaluate the Efficacy and Safety of VGR-R01 Gene Therapy in Patients With Bietti Crystalline Dystrophy
NCT06699108Bietti Crystalline Dystrophy, Inherited Retinal Diseases
Shanghai Vitalgen BioPharma Co., Ltd.
Phase 3
45
Shanghai
2024-12-13
Active, closed
Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants With Chronic Hepatitis B (CHB)
NCT06829329Chronic Hepatitis B
Ausper Biopharma Co., Ltd.
Phase 2
105
Chongqing, Fuzhou, Guangzhou, Changzhou, Zhenjiang, Hangzhou
2024-12-13
Recruiting
TACE Combined With Lenvatinib and PD-1 Inhibitor for Ruptured Hepatocellular Carcinoma
NCT06740370Hepatocellular Carcinoma, Transcatheter Arterial Chemoembolization, Anti-PD1 Antibody, Lenvatinib
Sun Yat-sen University
Not applicable
32
Beijing
2024-12-13
Recruiting
A Study on the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of SKB500 in Subjects With Advanced Solid Tumors
NCT06736327Advanced Solid Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 1
180
Jilin City
2024-12-13
Recruiting
Remote Anxiety Management for ICS-resistant Asthma Study
NCT06732141Asthma
First Affiliated Hospital of Ningbo University
Not applicable
216
Harbin, Hefei, Jingzhou, Ningbo, Ninghai, Taizhou
2024-12-13
Active, closed
A Study to Evaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) ABBV-400 in Combination With IV Fluorouracil, Leucovorin, and Budigalimab in Adult Participants With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
NCT06628310Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma
AbbVie
Phase 2
185
Beijing, Langfang, Harbin, Wuhan, Hangzhou
2024-12-13
Recruiting
Clinical Trial of HG146 Administered to Participants With Adenoid Cystic Carcinoma
NCT06781567Adenoid Cystic Carcinoma, Head and Neck Cancer
HitGen Inc.
Phase 2
140
Shanghai
2024-12-13
Recruiting
Normobaric Oxygen in AIS Transferred for EVT
NCT06666764Ischemic Stroke
Capital Medical University
Phase 3
1,500
Beijing, Fuzhou, Ningde, Putian, Zhangzhou, Guangzhou, Hezhou, Cangzhou
2024-12-13
Recruiting
Efficacy, Safety, and Immunogenicity of the Bivalent Inactivated Enterovirus Vaccine (Vero Cell)
NCT06734832Hand, Foot, and Mouth Disease๏ผˆHFMD)
Sinovac Biotech Co., Ltd
Phase 3
8,000
Hefei, Fujian, Guangdong, Hubei
2024-12-13
Recruiting
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
NCT06750094Colorectal Neoplasms
Janssen Research & Development, LLC
Phase 3
700
Beijing, Changchun, Changsha, Chengdu, Ganzhou, Guangzhou, Hangzhou, Harbin
2024-12-12
Recruiting
A Phase 2 Study to Evaluate the Efficacy and Safety of ENN0403 in Subjects with DME
NCT06708260Diabetic Macular Edema (DME)
EnnovaBio
Phase 2
60
Tianjin
2024-12-12
Recruiting
A Study on the Combined Use of Tocilizumab and Flupentixol-Melitracen in the Treatment of Thyroid-Associated Ophthalmopathy
NCT06927375Thyroid-Associated Ophthalmopathy
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 4
60
Shanghai
2024-12-12
Recruiting
Study of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer
NCT06584032Advanced Endometrial Cancer
Hutchmed
Phase 3
412
Beijing, Chongqing, Fuzhou, Guangzhou, Nanning, Harbin, Zhengzhou, Changsha
2024-12-12
Recruiting
A Clinical Trial of CEA Targeting CAR-T for CEA Positive Advanced Lung Cancer
NCT06768151Advanced Lung Cancer
Chongqing Precision Biotech Co., Ltd
Phase 1
48
Wuhan
2024-12-12
Recruiting
A Phase 1 Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of MK-6204 (SKB535) for Injection in Participants With Advanced Solid Tumors
NCT06726369Advanced Solid Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 1
90
Beijing, Changsha, Chengdu, Chongqing, Fuzhou, Shanghai, Wuhan
2024-12-12
Recruiting
TEOSYAL RHAยฎ 1 for the Correction of Moderate to Severe Tissue Volume Deficiency in the Infraorbital Region in Chinese Adults
NCT06749587Infraorbital Hollows
Teoxane SA
Not applicable
260
Guangzhou
2024-12-12
Recruiting
Surgical Competency for Robot-Assisted Thyroidectomy: Construction and Validation of a Robotic Thyroidectomy Assessment Score (RTAS)
NCT06730321Thyroid Cancer, Thyroid Nodule, Thyroid Diseases, Thyroid Cancer, Papillary
Shanghai 6th People's Hospital
Observational
200
Shanghai
2024-12-12
Recruiting
A Study of Neoadjuvant QL1706 in Participants With Untreated dMMR/MSI-H Resectable Colon Cancer
NCT06686576Colon Cancer
Qilu Pharmaceutical Co., Ltd.
Phase 3
363
Guangzhou
2024-12-12
Recruiting
A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed/ Refractory Multiple Myeloma
NCT06732232Relapsed, Refractory, Multiple Myeloma
Shanghai Cell Therapy Group Co.,Ltd
Phase EARLY_PHASE1
12
Shanghai
2024-12-12
Recruiting
Safety and Efficacy of CAR-T Cell Therapy for Relapsed/refractory Neuroblastoma and Desmoplastic Small Round Cell Tumors: a Single-arm, Open-label Trial.
NCT06836505Neuroblastoma (NB), Desmoplastic Small Round Cell Tumor (DSRCT)
Sun Yat-Sen University Cancer Center
Phase 1/2
10
Guangzhou, Dongguan, Shanghai
2024-12-12
Recruiting
Clinical Trial of CD123-targeted CAR-NK Therapy for Relapse/Refractory AML or BPDCN
NCT06690827AML (Acute Myeloid Leukemia), BPDCN (Blastic Plasmacytoid Dendritic Cell Neoplasm)
Chongqing Precision Biotech Co., Ltd
Phase 1
30
Wuhan
2024-12-12
Recruiting
Dose-escalation Study of D-CMG Regimen for the Treatment of Elderly Newly Diagnosed AML Patients
NCT06651866Acute Myeloid Leukemia
The First Affiliated Hospital of Xiamen University
Phase 1
18
Xiamen
2024-12-12
Recruiting
A Randomized Trial of Imaging Selection Modalities for Stroke Thrombectomy (NO-SELECT)
NCT05230914Stroke, Ischemic, Stroke, Acute
Xinqiao Hospital of Chongqing
Not applicable
1,846
Wuhu, Chongqing, Jiangmen, Haikou, Huai'an, Wuxi, Jingdezhen, Dalian
2024-12-12
Recruiting
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
NCT06716606Connective Tissue Diseases
GlaxoSmithKline
Phase 3
514
Beijing, Chengdu, Hangzhou, Mianyang, Shanghai, Shenyang, Zhuzhou
2024-12-12
Recruiting
A Study of SIGX1094R in Patients With Advanced Solid Tumors
NCT06739291Advanced Solid Tumors
Signet Therapeutics
Phase 1
102
Beijing
2024-12-12
Recruiting
Inhaled Nitric Oxide for the Treatment of Neonatal Hypoxic Respiratory Failure With Pulmonary Hypertension
NCT07099144Pulmonary Hypertension, Hypoxic Respiratory Failure
Lee's Pharmaceutical Limited
Observational
120
Guangzhou
2024-12-12
Recruiting
The Safety and Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy for Peritoneal Metastatic Adenocarcinoma
NCT06743867Peritoneal Carcinoma Metastatic
Guangdong Provincial People's Hospital
Phase 1
30
Guangzhou
2024-12-11
Recruiting
a Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Plasma Cell Leukemia
NCT06718270Relapsed/Refractory Multiple Myeloma, Relapsed/Refractory Plasma Cell Leukemia
Shanghai Changzheng Hospital
Phase EARLY_PHASE1
24
Shanghai
2024-12-11
Recruiting
A Study for the Treatment of Metastatic Prostate Cancer With HRS-1167 Tablets Combined With Abiraterone Acetate Tablets and Prednisone
NCT06689163Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2
66
Hefei, Changsha
2024-12-11
Recruiting
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.
NCT05421858Candidemia, Candidiasis, Invasive
Basilea Pharmaceutica
Phase 3
450
Beijing, Bengbu, Chengdu, Guangzhou, Hangzhou, Lishui, Liuzhou, Nanchang
2024-12-11
Recruiting
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
NCT06588855Moderately to Severely Active Ulcerative Colitis
Hoffmann-La Roche
Phase 3
350
Beijing, Kunming, Changsha, Chengdu, Guangzhou, Hangzhou, Huizhou, Nanchang
2024-12-11
Recruiting
Impact of Severe Obstructive Sleep Apnea-Hypopnea Syndrome on Auditory-Cognitive Processing
NCT07039500Obstructive Sleep Apnea, Auditory Processing Disorder
Peking University First Hospital
Observational
100
Beijing
2024-12-11
Not yet open
Evaluating an Insulin Pump for Time in Range (TIR) in Patients with Type 1 Diabetes
NCT06741943Type 1 Diabetes Mellitus, Insulin Pump, Time in Range
Tao Yuan๏ผŒMD
Not applicable
60
Beijing
2024-12-11
Active, closed
Optimal Combination of Adjuvant Radiotherapy and Immunotherapy for Breast Cancer
NCT07046195Hypofractionated Radiotherapy, Triple Negative Breast Cancer (TNBC), Immunotherapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
250
Guangzhou
2024-12-11
Recruiting
A Multicenter Prospective Study Evaluating Concurrent Chemoradiotherapy Following Induction Immunochemotherapy for Esophageal Cancer Based on Dynamic ctDNA Monitoring
NCT06792786Esophageal Cancer, ctDNA
The Central Hospital of Lishui City
Not applicable
30
Jinhua, Lishui
2024-12-10
Recruiting
Ultrasound-guided Thermal Ablation for Papillary Thyroid Carcinoma
NCT06733740Papillary Thyroid Cancer
Chinese PLA General Hospital
Observational
3,000
Beijing
2024-12-10
Recruiting
iGlarLixi CGM Study in Chinese T2D Individuals After OADs
NCT06671587Type 2 Diabetes (T2D)
Sanofi
Phase 4
678
Beijing
2024-12-10
Not yet open
Medial Enhancement Technique for the Treatment of Old Femoral Neck Fractures
NCT06713031Fracture of Neck of Femur
Chinese PLA General Hospital
Not applicable
400
Beijing
2024-12-10
Recruiting
Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Centrally Located Early-stage Non-small Cell Lung Cancer
NCT06730295Lung Cancer (NSCLC)
Sun Yat-sen University
Phase 2
52
Guangzhou
2024-12-10
Not yet open
Botulinum Toxin Injection Versus Prism Treatment in Small-angle Acute Acquired Concomitant Esotropia
NCT06714877Esotropia
Eye & ENT Hospital of Fudan University
Not applicable
100
Shanghai
2024-12-10
Recruiting
Efficacy and Safety of Triple-targeted Drug Therapy in Treatment-naive Patients With Non-low-risk PAH: A Real-world, Multicenter Study
NCT06753981Arterial Pulmonary Hypertension (PAH)
Qianfoshan Hospital
Observational
48
Jinan
2024-12-10
By invitation
The Effects of High-definition Transcranial Direct Current Stimulation on Balance Control in Older Adults With Chronic Low Back Pain
NCT06706479Chronic Low Back Pain
The Hong Kong Polytechnic University
Not applicable
48
Hong Kong
2024-12-10
Recruiting
A Clinical Study of SHR-3276 for Injection in Patients With Advanced Malignant Tumors
NCT06643754Advanced Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1/2
115
Chongqing
2024-12-10
Recruiting
Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for MRD-Positive B-ALL Patients in CR1
NCT06718244Acute Lymphoblastic Leukemia
Ruijin Hospital
Phase 2
20
Shanghai
2024-12-10
By invitation
A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Airway Mucus Hypersecretion
NCT06820749Asthma Bronchiale, Bronchiectasis, Chronic Obstructive Pulmonary Disease (COPD)
Haisco Pharmaceutical Group Co., Ltd.
Phase 2
309
Beijing
2024-12-10
Recruiting
Efficacy of Different Durations of Dual and Quadruple Regimens for Helicobacter Pylori Eradication
NCT06723197HELICOBACTER PYLORI INFECTIONS
Shandong University
Phase 4
330
Jinan
2024-12-10
Active, closed
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.
NCT06637631Crohn's Disease
Sanofi
Phase 2
260
Changzhou, Chongqing, Fuzhou, Guangzhou, Hangzhou, Hefei, Nanchang, Shanghai
2024-12-10
Recruiting
Clinical Study of a Novel Sliding Compression Locking Plate in the Treatment of Fresh Femoral Neck Fractures
NCT06713291Fracture of Femoral Neck
Chinese PLA General Hospital
Not applicable
1,150
Beijing
2024-12-10
Recruiting
Study on the Safety and Efficacy of Intravenous Administration of IDOV-SAFETM in the Treatment of Advanced Solid Tumors
NCT06718946Advanced Malignant Solid Tumor
Fudan University
Phase EARLY_PHASE1
38
Shanghai
2024-12-10
By invitation
Intervention Effects of High-intensity Tai Chi in Mild or Moderate Asthma
NCT06728904Asthma
Yufen Wu, MD
Not applicable
35
Shanghai
2024-12-10
Not yet open
Orthopedic Intelligent Navigation System in the Treatment of Fresh Femoral Neck Fractures
NCT06713018Fracture of Neck of Femur
Chinese PLA General Hospital
Not applicable
300
Beijing
2024-12-10
Recruiting
CR-CHOP+X in Previously Untreated DEL
NCT06701357DLBCL
Ruijin Hospital
Phase 2
49
Shanghai
2024-12-10
Recruiting
Establishment and Clinical Transformation of ADC Drug Efficacy Evaluation System for Breast Cancer Based on Molecular Imaging
NCT06715020Breast Cancer
Peking University Cancer Hospital & Institute
Not applicable
60
Beijing
2024-12-10
Recruiting
68Ga-MY6349 PET/CT in Solid Tumors
NCT07046702Solid Tumor, Trop2, PET/CT
The First Affiliated Hospital of Xiamen University
Observational
300
Xiamen
2024-12-10
Recruiting
Integrated Radiotherapy-optimized ASCT Sequential CAR-T Therapy for Patients With Relapsed and Refractory B-NHL
NCT07059741Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL)
The First Affiliated Hospital of Soochow University
Not applicable
20
Suzhou
2024-12-10
Active, closed
A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.
NCT06588686Idiopathic Pulmonary Fibrosis (IPF)
Vicore Pharma AB
Phase 2
378
2024-12-09
Recruiting
Minimum Power and Frequency of Repeated Low-level Red-light to Effectively Control Myopia Progression
NCT06717048Myopia, Refractive Error - Myopia, Choroidal Thickness, Retina
Shanghai Eye Disease Prevention and Treatment Center
Not applicable
108
Shanghai
2024-12-09
Recruiting
Ultrasound-guided Thermal Ablation for Bethesda III/IV Thyroid Nodules
NCT06733753Thyroid Nodule
Chinese PLA General Hospital
Observational
600
Beijing
2024-12-09
Active, closed
Application of 4DCT-Based Pulmonary Ventilation Imaging in Lung Cancer Radiotherapy
NCT07312682Lung Neoplasms, Radiation Pneumonitis
The Second Affiliated Hospital of Chongqing Medical University
Observational
202
Chongqing
2024-12-09
Recruiting
A Multi-mode Thermophysical Immunotherapy Study for Breast Cancer Liver Metastases
NCT06567353Breast Neoplasms, Liver Neoplasms, Metastasis
Ruijin Hospital
Not applicable
10
Shanghai
2024-12-09
Recruiting
Ultrasound-guided Thermal Ablation for Recurrent Thyroid Cancer
NCT06733766Recurrent Thyroid Cancer
Chinese PLA General Hospital
Observational
300
Beijing
2024-12-09
Recruiting
Clinical Trial of TQB3002 in Patients With Advanced Cancers
NCT06662760Advanced Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1
150
Guangzhou, Shenzhen, Zhengzhou, Nanjing, Nanchang, Shanghai, Xiโ€™an, Chengdu
2024-12-09
Recruiting
Long-term Follow-up Study of AL-001 Ophthalmic Injection in Subjects with WAMD
NCT06718816Wet Age-related Macular Degeneration (wAMD)
Beijing Anlong Biopharmaceutical Co., Ltd.
Observational
21
Beijing
2024-12-09
Recruiting
Predictive Value of Myelodysplastic Syndrome Stem Cells Determined by Multiparameter Flow Cytometry
NCT06569095Myelodysplastic Syndromes
Peking University People's Hospital
Observational
163
Beijing, Wuhan, Zhengzhou
2024-12-09
Recruiting
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
NCT06597019Familial Hypercholesterolemia - Heterozygous
Novartis Pharmaceuticals
Phase 3
60
Beijing, Shanghai
2024-12-09
Active, closed
Application of Targeted Axillary Lymph Node Resection in Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: an Open-label, Multicenter Study
NCT07032220Breast Cancer Surgery, Neoadjuvant Therapy, Sentinel Lymph Node Biopsy (SLNB)
Fujian Medical University Union Hospital
Not applicable
175
Fuzhou
2024-12-09
Recruiting
Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell Carcinoma
NCT07430579Pathological Complete Remission, Objective Response Rate, Immune-related Adverse Events, Quality of Life
The Second Hospital of Shandong University
Not applicable
25
Jinan
2024-12-09
Recruiting
Ultrasound-guided Thermal Ablation for Benign Thyroid Nodules
NCT06729762Thyroid Nodule (Benign)
Chinese PLA General Hospital
Observational
1,500
Beijing
2024-12-09
By invitation
Evaluating App-Based Vision Testing (WHOeyes) Combined With the Questionnaire as a Substitute for One-Week Postoperative In-Clinic Follow-Up in Age-Related Cataract Patients: A Multi-center Randomized Controlled Trial
NCT06429527Cataract Senile
Zhongshan Ophthalmic Center, Sun Yat-sen University
Not applicable
334
Guangzhou
2024-12-09
Rows per page Showing 10301–10400 of 19052
Previous 102 103 104 105 106 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china?page=104

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in China?

11,786 of the 19,052 studies in this register are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 3,920 have not yet opened recruitment, 2,668 are active but closed to new participants, and 678 are enrolling by invitation only. Eligibility for any study is decided by its study team.

→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.